Cancer type and gene signatures associated with breakthrough infections following COVID-19 mRNA vaccination
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Patients with B cell malignancies are most susceptible to breakthrough infections, indicating a need for enhanced COVID-19 immunizations in this group. Further research into specific gene expressions may improve immune protection.
Area Of Science
- Oncology
- Infectious Diseases
- Genetics
Background
- Breakthrough infections pose a significant risk to cancer patients, particularly those undergoing treatment.
- Identifying specific patient subgroups and molecular factors predisposing them to infections is crucial for effective management.
Purpose Of The Study
- To identify clinical and molecular determinants of breakthrough infections in cancer patients.
- To investigate the role of specific gene expressions in susceptibility to breakthrough infections.
Main Methods
- Utilized epidemiological data from 21,195 cancer patients and 180,407 matched controls.
- Conducted in-depth analyses on 216 cancer patients to explore clinical and molecular factors.
- Examined differential gene expression patterns in susceptible patient populations.
Main Results
- Patients with B cell malignancies exhibited the highest susceptibility to breakthrough infections.
- Differential expression of CD24, CDK14, and PLEKHG1 was observed in susceptible patients.
- These findings suggest a molecular basis for increased infection risk in specific cancer types.
Conclusions
- B cell malignancies are associated with a heightened risk of breakthrough infections.
- Specific gene expressions (CD24, CDK14, PLEKHG1) may serve as biomarkers for infection susceptibility.
- Targeted immunisation strategies, including additional booster doses, may be necessary for immunocompromised cancer patients to enhance immune protection against COVID-19.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...